Status
Conditions
Treatments
About
This study aims to:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Male or Female.
18 years old and above.
Sufficient written and oral expression in French.
Covered by a health insurance system
Written informed consent signed by the patient.
For the MS group:
* Patient diagnosed according to diagnostic criteria established by Polman et al. (2010): Radiologically Isolated Syndrome compatible with MS (RIS), Clinically Isolated Syndrome compatible with MS (CIS), Relapsing-Remitting MS, Secondary Progressive MS, or Primary Progressive MS.
* Hospitalized or coming to perform a consultation.
For the control group: No cognitive impairment (non pathological Mini-Mental State Examination (MMSE), according to age, gender and socio-cultural level).
Exclusion criteria
General anaesthesia within 3 months.
Ophthalmological problems preventing a video-oculography examination.
Oculomotor disorders:
Cognitive disorders of the type: visual agnosia, visuo-spatial disorder, visuo-perceptual disorder or aphasia.
Other neurological or ophthalmological disorders than MS
History of stroke.
Psychotropic drugs consummation.
Primary purpose
Allocation
Interventional model
Masking
76 participants in 6 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal